Variables · Breast staging sample
NODES¶
침범된 국소림프절-침범된 종류, 범위 · Regional nodes involved, and the kind and extent of involvement
- Dataset Breast staging sample (유방암 표본 병기)
- Table Cancer registration · 암_공공_병기조사_유방암_DB_암등록
- File
CS_BC_RGST - Type
VARCHAR(3)
Definition¶
Regional nodes involved, and the kind and extent of involvement.
Codes¶
| Code | 한글 | English |
|---|---|---|
0 |
No regional lymph node involvement OR isolated tumor cells (ITCs) detected by immunohistochemistry/immunohistochemical (IHC) methods or molecular methods ONLY. (See Note 7 and CS Site-Specific Factors 4 and 5) | No regional lymph node involvement OR isolated tumor cells (ITCs) detected by immunohistochemistry/immunohistochemical (IHC) methods or molecular methods ONLY. (See Note 7 and CS Site-Specific Factors 4 and 5) |
50 |
Evaluated pathologically: None; no regional lymph node involvement BUT ITCs detected on routine hematoxylin and eosin (H and E) stains. (See Note 7) | Evaluated pathologically: None; no regional lymph node involvement BUT ITCs detected on routine hematoxylin and eosin (H and E) stains. (See Note 7) |
130 |
Evaluated pathologically: Axillary lymph node(s), ipsilateral, micrometastasis ONLY detected by IHC ONLY (At least one micrometastasis greater than 0.2 mm or more than 200 cells AND all micrometastases less than or equal to 2mm) | Evaluated pathologically: Axillary lymph node(s), ipsilateral, micrometastasis ONLY detected by IHC ONLY (At least one micrometastasis greater than 0.2 mm or more than 200 cells AND all micrometastases less than or equal to 2mm) |
150 |
Evaluated pathologically: Axillary lymph node(s), ipsilateral, micrometastasis ONLY detected or verified on H&E (At least one micrometastasis greater than 0.2 mm or more than 200 cells AND all micrometastases less than or equal to 2 mm ) Micrometastasis, NOS | Evaluated pathologically: Axillary lymph node(s), ipsilateral, micrometastasis ONLY detected or verified on H&E (At least one micrometastasis greater than 0.2 mm or more than 200 cells AND all micrometastases less than or equal to 2 mm ) Micrometastasis, NOS |
155 |
Evaluated pathologically: Stated as N1mi with no other information on regional lymph nodes | Evaluated pathologically: Stated as N1mi with no other information on regional lymph nodes |
250 |
Evaluated pathologically: Movable axillary lymph node(s), ipsilateral, positive with more than micrometastasis (At least one metastasis greater than 2 mm) (See Note 4) | Evaluated pathologically: Movable axillary lymph node(s), ipsilateral, positive with more than micrometastasis (At least one metastasis greater than 2 mm) (See Note 4) |
255 |
Evaluated clinically: Clinically movable axillary lymph node(s), ipsilateral, positive (Clinical assessment because of neoadjuvant therapy or no pathology) (See Note 4) | Evaluated clinically: Clinically movable axillary lymph node(s), ipsilateral, positive (Clinical assessment because of neoadjuvant therapy or no pathology) (See Note 4) |
257 |
Evaluated clinically: Clinically stated only as N1 (Clinical assessment because of neoadjuvant therapy or no pathology) | Evaluated clinically: Clinically stated only as N1 (Clinical assessment because of neoadjuvant therapy or no pathology) |
258 |
Evaluated pathologically: Pathologically stated only as N1 [NOS], no information on which nodes were involved | Evaluated pathologically: Pathologically stated only as N1 [NOS], no information on which nodes were involved |
260 |
Stated as N1 [NOS] with no other information on regional lymph nodes | Stated as N1 [NOS] with no other information on regional lymph nodes |
510 |
Evaluated clinically: Fixed/matted ipsilateral axillary nodes clinically (Clinical assessment because of neoadjuvant therapy or no pathology) Stated clinically as N2a (Clinical assessment because of neoadjuvant therapy or no pathology) | Evaluated clinically: Fixed/matted ipsilateral axillary nodes clinically (Clinical assessment because of neoadjuvant therapy or no pathology) Stated clinically as N2a (Clinical assessment because of neoadjuvant therapy or no pathology) |
520 |
Evaluated pathologically: Fixed/matted ipsilateral axillary nodes clinically with pathologic involvement of lymph nodes WITH at least one metastasis greater than 2 mm | Evaluated pathologically: Fixed/matted ipsilateral axillary nodes clinically with pathologic involvement of lymph nodes WITH at least one metastasis greater than 2 mm |
600 |
Axillary/regional lymph node(s), NOS Lymph nodes, NOS | Axillary/regional lymph node(s), NOS Lymph nodes, NOS |
610 |
Evaluated clinically: Clinically stated only as N2 [NOS] (Clinical assessment because of neoadjuvant therapy or no pathology) | Evaluated clinically: Clinically stated only as N2 [NOS] (Clinical assessment because of neoadjuvant therapy or no pathology) |
620 |
Evaluated pathologically: Pathologically stated only as N2 [NOS]; no information on which nodes were involved | Evaluated pathologically: Pathologically stated only as N2 [NOS]; no information on which nodes were involved |
630 |
Stated as N2 [NOS] with no other information on regional lymph nodes | Stated as N2 [NOS] with no other information on regional lymph nodes |
710 |
Evaluated pathologically: Internal mammary node(s), ipsilateral, positive on sentinel nodes but not clinically apparent (No positive imaging or clinical exam) WITHOUT axillary lymph node(s), ipsilateral | Evaluated pathologically: Internal mammary node(s), ipsilateral, positive on sentinel nodes but not clinically apparent (No positive imaging or clinical exam) WITHOUT axillary lymph node(s), ipsilateral |
720 |
Evaluated pathologically: Internal mammary node(s), ipsilateral, positive on sentinel nodes but not clinically apparent (No positive imaging or clinical exam) WITH axillary lymph node(s), ipsilateral | Evaluated pathologically: Internal mammary node(s), ipsilateral, positive on sentinel nodes but not clinically apparent (No positive imaging or clinical exam) WITH axillary lymph node(s), ipsilateral |
730 |
Evaluated pathologically: Internal mammary node(s), ipsilateral, positive on sentinel nodes but not clinically apparent (No positive imaging or clinical exam) UNKNOWN if positive axillary lymph node(s), ipsilateral | Evaluated pathologically: Internal mammary node(s), ipsilateral, positive on sentinel nodes but not clinically apparent (No positive imaging or clinical exam) UNKNOWN if positive axillary lymph node(s), ipsilateral |
735 |
Evaluated clinically: Internal mammary node(s), ipsilateral, positive on sentinel nodes but primary not resected WITHOUT axillary lymph node(s), ipsilateral OR UNKNOWN if positive axillary lymph node(s), | Evaluated clinically: Internal mammary node(s), ipsilateral, positive on sentinel nodes but primary not resected WITHOUT axillary lymph node(s), ipsilateral OR UNKNOWN if positive axillary lymph node(s), |
740 |
Internal mammary node(s), ipsilateral, clinically apparent (On imaging or clinical exam) WITHOUT axillary lymph node(s), ipsilateral | Internal mammary node(s), ipsilateral, clinically apparent (On imaging or clinical exam) WITHOUT axillary lymph node(s), ipsilateral |
745 |
Internal mammary node(s), ipsilateral, clinically apparent (On imaging or clinical exam) UNKNOWN if positive axillary lymph node(s), ipsilateral | Internal mammary node(s), ipsilateral, clinically apparent (On imaging or clinical exam) UNKNOWN if positive axillary lymph node(s), ipsilateral |
748 |
Stated as N2b with no other information on regional lymph nodes | Stated as N2b with no other information on regional lymph nodes |
750 |
Infraclavicular lymph node(s)(subclavicular) (level III axillary nodes) (apical), ipsilateral WITH or WITHOUT axillary nodes(s) WITHOUT internal mammary node(s) | Infraclavicular lymph node(s)(subclavicular) (level III axillary nodes) (apical), ipsilateral WITH or WITHOUT axillary nodes(s) WITHOUT internal mammary node(s) |
755 |
Stated as N3a with no other information on regional lymph nodes | Stated as N3a with no other information on regional lymph nodes |
763 |
Internal mammary node(s), ipsilateral, clinically apparent (On imaging or clinical exam) WITH axillary lymph node(s), ipsilateral, codes 150 to 600 WITHOUT infraclavicular (level III axillary nodes) (apical) lymph nodes or unknown if infraclavicular (level III axillary nodes) (apical) lymph nodes involved | Internal mammary node(s), ipsilateral, clinically apparent (On imaging or clinical exam) WITH axillary lymph node(s), ipsilateral, codes 150 to 600 WITHOUT infraclavicular (level III axillary nodes) (apical) lymph nodes or unknown if infraclavicular (level III axillary nodes) (apical) lymph nodes involved |
764 |
Internal mammary node(s), ipsilateral, clinically apparent (On imaging or clinical exam) WITHOUT axillary lymph node(s), ipsilateral WITH infraclavicular (level III axillary nodes) (apical) lymph nodes involved | Internal mammary node(s), ipsilateral, clinically apparent (On imaging or clinical exam) WITHOUT axillary lymph node(s), ipsilateral WITH infraclavicular (level III axillary nodes) (apical) lymph nodes involved |
765 |
Internal mammary node(s), ipsilateral, clinically apparent (On imaging or clinical exam) WITH axillary lymph node(s), ipsilateral WITH infraclavicular (level III axillary nodes) (apical) lymph nodes involved | Internal mammary node(s), ipsilateral, clinically apparent (On imaging or clinical exam) WITH axillary lymph node(s), ipsilateral WITH infraclavicular (level III axillary nodes) (apical) lymph nodes involved |
768 |
Stated as N3b with no other information on regional lymph nodes | Stated as N3b with no other information on regional lymph nodes |
800 |
Supraclavicular node(s), ipsilateral | Supraclavicular node(s), ipsilateral |
805 |
Stated as N3c with no other information on regional lymph nodes | Stated as N3c with no other information on regional lymph nodes |
810 |
Evaluated clinically: Clinically stated only as N3 [NOS] (Clinical assessment because of neoadjuvant therapy or no pathology) | Evaluated clinically: Clinically stated only as N3 [NOS] (Clinical assessment because of neoadjuvant therapy or no pathology) |
815 |
Evaluated pathologically: Pathologically stated only as N3 [NOS]; no information on which nodes were involved | Evaluated pathologically: Pathologically stated only as N3 [NOS]; no information on which nodes were involved |
820 |
Stated as N3, NOS with no other information on regional lymph nodes | Stated as N3, NOS with no other information on regional lymph nodes |
999 |
Unknown; regional lymph nodes not stated Regional lymph node(s) cannot be assessed Not documented in patient record | Unknown; regional lymph nodes not stated Regional lymph node(s) cannot be assessed Not documented in patient record |
The catalog records these codes as valid from 2012 through 2019.
Catalog note¶
침범된 국소림프절-침범된 종류, 범위
예) 400 → Celiac
The Korean text is from the portal data catalog for this 표본 병기 database, downloaded 30 October 2026 (국가암데이터센터_암공공_표본_병기_유방암_261030113608.xlsx). The English is a translation for this site. The catalog says that code values beyond this sheet are on the Health Insurance Review and Assessment Service open-data system.